PRELUDE THERAPEUTICS INC's ticker is PRLD and the CUSIP is 74065P101. A total of 61 filers reported holding PRELUDE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 6.00 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11,235 | -40.8% | 3,636 | -13.8% | 0.00% | – |
| Q2 2023 | $18,990 | +1770.9% | 4,220 | +2270.8% | 0.00% | – |
| Q1 2023 | $1,015 | -50.9% | 178 | -48.0% | 0.00% | – |
| Q4 2022 | $2,066 | +3.3% | 342 | -7.8% | 0.00% | – |
| Q3 2022 | $2,000 | +100.0% | 371 | +98.4% | 0.00% | – |
| Q2 2022 | $1,000 | 0.0% | 187 | +87.0% | 0.00% | – |
| Q1 2022 | $1,000 | -97.4% | 100 | -96.8% | 0.00% | – |
| Q4 2021 | $39,000 | +1850.0% | 3,152 | +7230.2% | 0.00% | – |
| Q3 2021 | $2,000 | +100.0% | 43 | 0.0% | 0.00% | – |
| Q2 2021 | $1,000 | -97.7% | 43 | -95.8% | 0.00% | – |
| Q1 2021 | $44,000 | -87.2% | 1,015 | -78.9% | 0.00% | – |
| Q4 2020 | $344,000 | – | 4,806 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Orbimed Advisors | 10,039,691 | $69,274,000 | 1.12% |
| Baker Brothers Advisors | 10,123,824 | $69,854,000 | 0.40% |
| HHLR ADVISORS, LTD. | 583,333 | $4,025,000 | 0.08% |
| Rock Springs Capital Management LP | 368,959 | $2,546,000 | 0.06% |
| PDT Partners, LLC | 71,822 | $496,000 | 0.04% |
| Virtus ETF Advisers LLC | 13,048 | $90,000 | 0.04% |
| Corton Capital Inc. | 10,918 | $75,000 | 0.03% |
| GSA CAPITAL PARTNERS LLP | 23,201 | $160,000 | 0.02% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 24,238 | $167,000 | 0.01% |
| IndexIQ Advisors LLC | 56,750 | $392,000 | 0.01% |